name,category,termsADAMTS-like 4,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450009363$IPR010294:ADAM-TS Spacer 1, 450009938$IPR010909:PLAC]
ADAMTS-like 4,OMIM_DISEASE[520001646$Ectopia lentis, isolated, autosomal recessive]
ADAMTS-like 4,SMART[760000182$SM00209:TSP1]
ADAMTS-like 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
ADAMTS-like 4,UP_SEQ_FEATURE[850003827$chain:ADAMTS-like protein 4, 850102586$compositionally biased region:Pro-rich, 850105021$domain:PLAC, 850105555$domain:TSP type-1 1, 850105566$domain:TSP type-1 2, 850105575$domain:TSP type-1 3, 850105576$domain:TSP type-1 4, 850105577$domain:TSP type-1 5, 850105578$domain:TSP type-1 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),COG_ONTOLOGY[90000121$Transcription / DNA replication, recombination, and repair]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),INTERPRO[450000283$IPR000330:SNF2-related, 450000307$IPR000357:HEAT, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010814$IPR011989:Armadillo-like helical, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),UP_SEQ_FEATURE[850063604$chain:TATA-binding protein-associated factor 172, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850117399$short sequence motif:DEGH box, 850117610$short sequence motif:Nuclear localization signal]
CDC42 small effector 1,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 1,SMART[760000256$SM00285:PBD]
CDC42 small effector 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 1,UP_SEQ_FEATURE[850010188$chain:CDC42 small effector protein 1, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850113403$region of interest:Mediates phosphoinositide-binding, 850118574$splice variant]
EPH receptor A8,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000955$IPR001090:Ephrin receptor, ligand binding, 450001096$IPR001245:Tyrosine protein kinase, 450001270$IPR001426:Receptor tyrosine kinase, class V, conserved site, 450001470$IPR001660:Sterile alpha motif SAM, 450003484$IPR003961:Fibronectin, type III, 450003485$IPR003962:Fibronectin, type III subdomain, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450012380$IPR013761:Sterile alpha motif-type, 450014581$IPR016257:Tyrosine-protein kinase, ephrin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
EPH receptor A8,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
EPH receptor A8,PIR_SUPERFAMILY[630000780$PIRSF000666:TyrPK_ephrin_receptor]
EPH receptor A8,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000399$SM00454:SAM, 760000544$SM00615:EPH_lbd]
EPH receptor A8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
EPH receptor A8,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850017618$chain:Ephrin type-A receptor 8, 850102480$compositionally biased region:Cys-rich, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105086$domain:Protein kinase, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA1217,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1217,UP_SEQ_FEATURE[850060708$chain:Sickle tail protein homolog, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850105829$glycosylation site:O-linked (GlcNAc), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MYST histone acetyltransferase (monocytic leukemia) 4,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002410$IPR002717:MOZ/SAS-like protein, 450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,SMART[760000221$SM00249:PHD, 760000466$SM00526:H15]
MYST histone acetyltransferase (monocytic leukemia) 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,UP_SEQ_FEATURE[850023870$chain:Histone acetyltransferase MYST4, 850102562$compositionally biased region:Met-rich, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850111190$region of interest:Catalytic, 850112133$region of interest:Interaction with BRPF1, 850112798$region of interest:Interaction with RUNX1 and RUNX2, 850113734$region of interest:Negatively regulates HAT activity, 850117294$sequence conflict, 850117295$sequence variant, 850117914$site:Breakpoint for translocation to form MYST4-CREBBP, 850118574$splice variant, 850118743$zinc finger region:C2HC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
N-acetyltransferase 11 (GCN5-related, putative),INTERPRO[450000154$IPR000182:GCN5-related N-acetyltransferase, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
N-acetyltransferase 11 (GCN5-related, putative),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001547$transferase]
N-acetyltransferase 11 (GCN5-related, putative),UP_SEQ_FEATURE[850033228$chain:N-acetyltransferase 11, 850104817$domain:N-acetyltransferase, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict, 850118574$splice variant]
N-myristoyltransferase 2,INTERPRO[450000786$IPR000903:Myristoyl-CoA:protein N-myristoyltransferase, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
N-myristoyltransferase 2,PIR_SUPERFAMILY[630012660$PIRSF015892:N-myristl_transf, 630012661$PIRSF015892:N-myristoyl transferase]
N-myristoyltransferase 2,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001547$transferase]
N-myristoyltransferase 2,UP_SEQ_FEATURE[850022174$chain:Glycylpeptide N-tetradecanoyltransferase 2, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117294$sequence conflict]
RAB3 GTPase activating protein subunit 2 (non-catalytic),OMIM_DISEASE[520003082$Martsolf syndrome]
RAB3 GTPase activating protein subunit 2 (non-catalytic),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000252$cataract, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000640$GTPase activation, 790000930$mental retardation, 790001162$phosphoprotein, 790001212$polymorphism]
RAB3 GTPase activating protein subunit 2 (non-catalytic),UP_SEQ_FEATURE[850056534$chain:Rab3 GTPase-activating protein non- catalytic subunit, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
S100 calcium binding protein A7-like 2,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A7-like 2,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A7-like 2,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000937$metal-binding, 790001304$repeat, 790001648$zinc]
S100 calcium binding protein A7-like 2,UP_SEQ_FEATURE[850000624$calcium-binding region:2; high affinity, 850047566$chain:Protein S100-A7-like 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106218$metal ion-binding site:Zinc]
S100 calcium binding protein A8,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A8,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000100$Antimicrobial, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000480$EF hand, 790000679$heterodimer, 790000701$homodimer, 790000774$inflammation, 790000919$membrane, 790001304$repeat, 790001363$Secreted]
S100 calcium binding protein A8,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047568$chain:Protein S100-A8, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand]
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae),INTERPRO[450011887$IPR013252:Kinetochore-Ndc80 subunit Spc24]
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000827$kinetochore, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein]
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae),UP_SEQ_FEATURE[850027543$chain:Kinetochore protein Spc24, 850105852$helix, 850106258$modified residue, 850112923$region of interest:Interaction with the C-terminus of SPBC25, 850112936$region of interest:Interaction with the N-terminus of SPBC25, 850112937$region of interest:Interaction with the NDC80-CDCA1 subcomplex, 850118624$turn]
TNFAIP3 interacting protein 1,PIR_SUPERFAMILY[630029928$PIRSF038355:Nef-associated factor 1]
TNFAIP3 interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TNFAIP3 interacting protein 1,UP_SEQ_FEATURE[850064558$chain:TNFAIP3-interacting protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113099$region of interest:Interacts with Nef, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
TRAF2 and NCK interacting kinase,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001035$IPR001180:Citron-like, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
TRAF2 and NCK interacting kinase,OMIM_DISEASE[520000067$A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype]
TRAF2 and NCK interacting kinase,SMART[760000028$SM00036:CNH, 760000193$SM00220:S_TKc]
TRAF2 and NCK interacting kinase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
TRAF2 and NCK interacting kinase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850064873$chain:Traf2 and NCK-interacting protein kinase, 850103376$domain:CNH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
adenosine kinase,INTERPRO[450001598$IPR001805:Adenosine kinase, 450001928$IPR002173:Carbohydrate/puine kinase, PfkB, conserved site, 450010441$IPR011611:Carbohydrate/purine kinase]
adenosine kinase,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenosine kinase,PIR_SUPERFAMILY[630005929$PIRSF005991:adenosine kinase]
adenosine kinase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001280$purine salvage, 790001547$transferase]
adenosine kinase,UP_SEQ_FEATURE[850003869$chain:Adenosine kinase, 850105852$helix, 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenylate kinase 2,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 2,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 2,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001097$P-loop, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 2,UP_SEQ_FEATURE[850000229$binding site:AMP, 850003913$chain:Adenylate kinase 2, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12,UP_SEQ_FEATURE[850005183$chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein, 850106258$modified residue, 850117295$sequence variant]
ataxin 3,COG_ONTOLOGY[90000115$Transcription]
ataxin 3,INTERPRO[450003428$IPR003903:Ubiquitin interacting motif, 450005587$IPR006155:Machado-Joseph disease protein MJD]
ataxin 3,OMIM_DISEASE[520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003001$Machado-Joseph disease, 520003072$Many sequence variants affecting diversity of adult human height]
ataxin 3,SMART[760000632$SM00726:UIM]
ataxin 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001015$neurodegeneration, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001431$spinocerebellar ataxia, 790001509$thiol protease, 790001539$Transcription, 790001543$transcription regulation, 790001569$triplet repeat expansion]
ataxin 3,UP_SEQ_FEATURE[850006401$chain:Ataxin-3, 850102570$compositionally biased region:Poly-Gln, 850104490$domain:Josephin, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850117164$repeat:UIM 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
basic leucine zipper nuclear factor 1,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
basic leucine zipper nuclear factor 1,INTERPRO[450011820$IPR013183:Protein of unknown function DUF1721, fungi]
basic leucine zipper nuclear factor 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000510$er-golgi transport, 790000624$golgi apparatus, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
basic leucine zipper nuclear factor 1,UP_SEQ_FEATURE[850022260$chain:Golgin-45, 850106258$modified residue, 850111631$region of interest:Essential for the interaction with GORASP2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
carcinoembryonic antigen-related cell adhesion molecule 4,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 4,SMART[760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
carcinoembryonic antigen-related cell adhesion molecule 4,UP_SEQ_FEATURE[850009690$chain:Carcinoembryonic antigen-related cell adhesion molecule 4, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
centromere protein M,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000827$kinetochore, 790001065$nucleus]
centromere protein M,UP_SEQ_FEATURE[850010664$chain:Centromere protein M, 850118574$splice variant]
chromosome 1 open reading frame 68,INTERPRO[450002847$IPR003267:Small proline-rich]
chromosome 1 open reading frame 68,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 68,UP_SEQ_FEATURE[850060914$chain:Skin-specific protein 32, 850102480$compositionally biased region:Cys-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 1 open reading frame 77,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 1 open reading frame 77,UP_SEQ_FEATURE[850073668$chain:Uncharacterized protein C1orf77, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
chromosome 10 open reading frame 113,INTERPRO[450000372$IPR000435:Tektin]
chromosome 10 open reading frame 113,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 10 open reading frame 113,UP_SEQ_FEATURE[850055183$chain:Putative uncharacterized protein C10orf113, 850117295$sequence variant]
cingulin-like 1,INTERPRO[450002582$IPR002928:Myosin tail]
cingulin-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001528$Tight junction]
cingulin-like 1,UP_SEQ_FEATURE[850011495$chain:Cingulin-like protein 1, 850102568$compositionally biased region:Poly-Asp, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850111838$region of interest:Head, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850117805$short sequence motif:ZIM, 850118574$splice variant]
coronin, actin binding protein, 2B,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2B,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2B,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2B,UP_SEQ_FEATURE[850012629$chain:Coronin-2B, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cysteine/histidine-rich 1,INTERPRO[450001138$IPR001293:Zinc finger, TRAF-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
cysteine/histidine-rich 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
cysteine/histidine-rich 1,UP_SEQ_FEATURE[850013241$chain:Cysteine and histidine-rich protein 1, 850118574$splice variant, 850118920$zinc finger region:RING-type; degenerate, 850118936$zinc finger region:TRAF-type]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
dynactin 5 (p25),INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat]
dynactin 5 (p25),OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
dynactin 5 (p25),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
dynactin 5 (p25),UP_SEQ_FEATURE[850016482$chain:Dynactin subunit 5]
electron-transfer-flavoprotein, alpha polypeptide,COG_ONTOLOGY[90000064$Energy production and conversion]
electron-transfer-flavoprotein, alpha polypeptide,INTERPRO[450001152$IPR001308:Electron transfer flavoprotein, alpha subunit, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013181$IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal, 450013182$IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal, 450016493$IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site]
electron-transfer-flavoprotein, alpha polypeptide,OMIM_DISEASE[520002133$Glutaricaciduria, type IIA]
electron-transfer-flavoprotein, alpha polypeptide,PIR_SUPERFAMILY[630000101$PIRSF000089:Electra_flavoP_a, 630000102$PIRSF000089:electron transfer flavoprotein, alpha subunit]
electron-transfer-flavoprotein, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000489$electron transport, 790000537$FAD, 790000559$Flavoprotein, 790000601$Glutaricaciduria, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide, 790001558$transport]
electron-transfer-flavoprotein, alpha polypeptide,UP_SEQ_FEATURE[850017044$chain:Electron transfer flavoprotein subunit alpha, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
ets variant 7,INTERPRO[450000358$IPR000418:Ets, 450002742$IPR003118:Sterile alpha motif/pointed, 450010816$IPR011991:Winged helix repressor DNA-binding, 450012380$IPR013761:Sterile alpha motif-type]
ets variant 7,KEGG_PATHWAY[470038847$hsa04320:Dorso-ventral axis formation]
ets variant 7,SMART[760000223$SM00251:SAM_PNT, 760000360$SM00413:ETS]
ets variant 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 7,UP_SEQ_FEATURE[850065164$chain:Transcription factor ETV7, 850102913$DNA-binding region:ETS, 850105048$domain:PNT, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,INTERPRO[450001666$IPR001884:Eukaryotic initiation factor 5A hypusine (eIF-5A), 450001667$IPR001884:Translation elongation factor, IF5A, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450013174$IPR014722:Translation protein SH3-like, subgroup, 450018003$IPR019769:Eukaryotic initiation factor 5A, hypusine site, 450018004$IPR019769:Translation elongation factor, IF5A, hypusine site]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,PIR_SUPERFAMILY[630003113$PIRSF003025:eIF5A, 630003114$PIRSF003025:translation initiation factor eIF-5A]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000491$elongation factor, 790000499$endoplasmic reticulum, 790000754$hypusine, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001266$protein transport, 790001339$rna-binding, 790001554$translocation, 790001558$transport]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,UP_SEQ_FEATURE[850018152$chain:Eukaryotic translation initiation factor 5A-1, 850018153$chain:Eukaryotic translation initiation factor 5A-1-like, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111472$region of interest:DOHH-binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
formin binding protein 1-like,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain, 450002649$IPR003016:2-oxo acid dehydrogenase, lipoyl-binding site]
formin binding protein 1-like,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
formin binding protein 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000410$cytoskeleton, 790000496$Endocytosis, 790000876$lipid-binding, 790000919$membrane, 790001162$phosphoprotein, 790001398$sh3 domain]
formin binding protein 1-like,UP_SEQ_FEATURE[850019956$chain:Formin-binding protein 1-like, 850103755$domain:FCH, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850112020$region of interest:Induction of membrane tubulation, 850112162$region of interest:Interaction with CDC42, 850112242$region of interest:Interaction with DAAM1, DIAPH1 and DIAPH2, 850112262$region of interest:Interaction with DNM1, 850112265$region of interest:Interaction with DNM2 and WASL, 850116917$repeat:REM, 850118574$splice variant]
human immunodeficiency virus type I enhancer binding protein 3,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
human immunodeficiency virus type I enhancer binding protein 3,PIR_SUPERFAMILY[630003880$PIRSF003876:HIV-EP2 enhancer-binding protein]
human immunodeficiency virus type I enhancer binding protein 3,SMART[760000323$SM00355:ZnF_C2H2]
human immunodeficiency virus type I enhancer binding protein 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
human immunodeficiency virus type I enhancer binding protein 3,UP_SEQ_FEATURE[850065201$chain:Transcription factor HIVEP3, 850102513$compositionally biased region:Glu/Pro-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850110585$region of interest:6 X 4 AA tandem repeats of S-P-X-[RK], 850110826$region of interest:Acidic 1, 850110827$region of interest:Acidic 2, 850110828$region of interest:Acidic 3, 850113749$region of interest:No DNA binding activity or transactivation activity, but complete prevention of TRAF-dependent NF-Kappa-B activation; associates with TRAF2 and JUN, 850115065$region of interest:ZAS1, 850115066$region of interest:ZAS2, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118721$zinc finger region:C2H2-type 3; degenerate, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
involucrin,INTERPRO[450000304$IPR000354:Involucrin repeat, 450002099$IPR002360:Involucrin, 450017808$IPR019571:Involucrin, N-terminal, 450017981$IPR019743:Involucrin, conserved site]
involucrin,PIR_SUPERFAMILY[630002382$PIRSF002252:involucrin]
involucrin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000377$cornified cell envelope, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000506$epidermis, 790000811$isopeptide bond, 790000822$keratinization, 790000881$lipoprotein, 790001212$polymorphism, 790001304$repeat, 790001484$tandem repeat]
involucrin,UP_SEQ_FEATURE[850026720$chain:Involucrin, 850102735$cross-link:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in other proteins), 850105852$helix, 850105884$lipid moiety-binding region:Omega-hydroxyceramide glutamate ester, 850110336$region of interest:39 X 10 AA approximate tandem repeats of [LP]-[EKG]-[LHVYQEK]-[PLSQE]-[EQDV]- [QHEKRGA]-Q-[EMVQLP]-[GKLE]-[QHVNLD], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115391$repeat:24; approximate, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115445$repeat:31, 850115447$repeat:32, 850115449$repeat:33, 850115451$repeat:34, 850115453$repeat:35, 850115456$repeat:36; approximate, 850115457$repeat:37, 850115459$repeat:38, 850115462$repeat:39; approximate, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117295$sequence variant]
keratin 86,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 86,OMIM_DISEASE[520003364$Monilethrix]
keratin 86,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 86,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000788$Intermediate filament, 790000821$keratin]
keratin 86,UP_SEQ_FEATURE[850027200$chain:Keratin, type II cuticular Hb6, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
low density lipoprotein receptor,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000170$h_LDLpathway:Low-density lipoprotein (LDL) pathway during atherogenesis, 30000264$h_s1pPathway:SREBP control of lipid synthesis]
low density lipoprotein receptor,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
low density lipoprotein receptor,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002416$Hypercholesterolemia, familial, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
low density lipoprotein receptor,PIR_SUPERFAMILY[630002100$PIRSF001961:LDL receptor]
low density lipoprotein receptor,SMART[760000117$SM00135:LY, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000303$cholesterol, 790000305$cholesterol metabolism, 790000334$coated pit, 790000335$coated pits, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000733$host-virus interaction, 790000842$LDL, 790000873$lipid metabolism, 790000875$lipid transport, 790000881$lipoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001442$steroid metabolism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
low density lipoprotein receptor,UP_SEQ_FEATURE[850029114$chain:low-density lipoprotein receptor, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850104700$domain:LDL-receptor class A 4, 850104701$domain:LDL-receptor class A 5, 850104703$domain:LDL-receptor class A 6, 850104705$domain:LDL-receptor class A 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111262$region of interest:Clustered O-linked oligosaccharides, 850116264$repeat:LDL-receptor class B 1, 850116275$repeat:LDL-receptor class B 2, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,INTERPRO[450011589$IPR012913:Glucosidase II beta subunit-like]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000243$carcinogenesis, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000848$Lectin, 790001212$polymorphism, 790001405$signal]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,UP_SEQ_FEATURE[850047109$chain:Protein OS-9, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850105082$domain:PRKCSH, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
pancreatic polypeptide,INTERPRO[450001731$IPR001955:Pancreatic hormone, 450001732$IPR001955:Pancreatic hormone-like, 450013920$IPR015480:Pancreatic hormone, 450013921$IPR015480:Pancreatic hormone subtype]
pancreatic polypeptide,PIR_SUPERFAMILY[630001984$PIRSF001845:pancreatic hormone]
pancreatic polypeptide,SMART[760000279$SM00309:PAH]
pancreatic polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000708$hormone, 790001137$pharmaceutical, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
pancreatic polypeptide,UP_SEQ_FEATURE[850105852$helix, 850106258$modified residue, 850108632$peptide:Pancreatic hormone, 850108633$peptide:Pancreatic icosapeptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
papillary renal cell carcinoma (translocation-associated),INTERPRO[450017072$IPR018800:Mitotic checkpoint protein PRCC, C-terminal]
papillary renal cell carcinoma (translocation-associated),OMIM_DISEASE[520004228$Renal cell carcinoma, papillary, 1]
papillary renal cell carcinoma (translocation-associated),SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene]
papillary renal cell carcinoma (translocation-associated),UP_SEQ_FEATURE[850044624$chain:Proline-rich protein PRCC, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117295$sequence variant]
patatin-like phospholipase domain containing 2,INTERPRO[450002343$IPR002641:Patatin]
patatin-like phospholipase domain containing 2,OMIM_DISEASE[520003621$Neutral lipid storage disease with myopathy]
patatin-like phospholipase domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000869$lipid degradation, 790000871$lipid droplet, 790000873$lipid metabolism, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
patatin-like phospholipase domain containing 2,UP_SEQ_FEATURE[850036892$chain:Patatin-like phospholipase domain- containing protein 2, 850104907$domain:Patatin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117474$short sequence motif:GXSXG, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
phosphorylase, glycogen, liver,INTERPRO[450000704$IPR000811:Glycosyl transferase, family 35, 450010659$IPR011833:Glycogen/starch/alpha-glucan phosphorylase]
phosphorylase, glycogen, liver,KEGG_PATHWAY[470038765$hsa00500:Starch and sucrose metabolism, 470038882$hsa04910:Insulin signaling pathway]
phosphorylase, glycogen, liver,OMIM_DISEASE[520002153$Glycogen storage disease VI]
phosphorylase, glycogen, liver,PIR_SUPERFAMILY[630000541$PIRSF000460:glucan phosphorylase, 630000542$PIRSF000460:Pprylas_GlgP]
phosphorylase, glycogen, liver,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000045$allosteric enzyme, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000446$disease mutation, 790000610$glycogen metabolism, 790000611$glycogen storage disease, 790000619$glycosyltransferase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
phosphorylase, glycogen, liver,UP_SEQ_FEATURE[850000229$binding site:AMP, 850022044$chain:Glycogen phosphorylase, liver form, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118388$site:Involved in the association of subunits, 850118409$site:May be involved in allosteric control, 850118575$strand, 850118624$turn]
poly(A) binding protein, cytoplasmic 4 (inducible form),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450001775$IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein, 450005938$IPR006515:Polyadenylate binding protein, human types 1, 2, 3, 4, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
poly(A) binding protein, cytoplasmic 4 (inducible form),PIR_SUPERFAMILY[630002203$PIRSF002074:polyadenylate-binding protein]
poly(A) binding protein, cytoplasmic 4 (inducible form),SMART[760000328$SM00360:RRM, 760000459$SM00517:PolyA]
poly(A) binding protein, cytoplasmic 4 (inducible form),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000953$methylation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
poly(A) binding protein, cytoplasmic 4 (inducible form),UP_SEQ_FEATURE[850039789$chain:Polyadenylate-binding protein 4, 850102565$compositionally biased region:Poly-Ala, 850104879$domain:PABC, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105216$domain:RRM 4, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
progestin and adipoQ receptor family member V,BIOCARTA[30000191$h_mPRPathway:How Progesterone Initiates the Oocyte Maturation]
progestin and adipoQ receptor family member V,INTERPRO[450003761$IPR004254:Hly-III related]
progestin and adipoQ receptor family member V,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000876$lipid-binding, 790000919$membrane, 790001077$oogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001443$steroid-binding, 790001555$transmembrane]
progestin and adipoQ receptor family member V,UP_SEQ_FEATURE[850031090$chain:Membrane progestin receptor gamma, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
proline rich 15,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790001212$polymorphism]
proline rich 15,UP_SEQ_FEATURE[850044602$chain:Proline-rich protein 15, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
prostaglandin E synthase 2,INTERPRO[450001869$IPR002109:Glutaredoxin, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450010594$IPR011767:Glutaredoxin active site, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
prostaglandin E synthase 2,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
prostaglandin E synthase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000542$Fatty acid biosynthesis, 790000624$golgi apparatus, 790000810$Isomerase, 790000874$lipid synthesis, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001249$prostaglandin biosynthesis, 790001555$transmembrane]
prostaglandin E synthase 2,UP_SEQ_FEATURE[850044708$chain:Prostaglandin E synthase 2, 850044709$chain:Prostaglandin E synthase 2 truncated form, 850104060$domain:Glutaredoxin, 850104084$domain:GST C-terminal, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
selenoprotein N, 1,INTERPRO[450016534$IPR018249:EF-HAND 2]
selenoprotein N, 1,OMIM_DISEASE[520003443$Muscular dystrophy, rigid spine, 1]
selenoprotein N, 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000425$desmin-related myopathy, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001368$selenium, 790001370$selenocysteine, 790001405$signal]
selenoprotein N, 1,UP_SEQ_FEATURE[850059266$chain:Selenoprotein N, 850102378$compositionally biased region:Ala-rich, 850103571$domain:EF-hand, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),SMART[760000193$SM00220:S_TKc]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),SP_PIR_KEYWORDS[790000050$alternative initiation, 790000053$alternative splicing, 790000109$Apoptosis, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010430$chain:Cell division protein kinase 11A, 850010431$chain:Cell division protein kinase 11B, 850102507$compositionally biased region:Glu-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
similar to hCG1991431; similar to COMPase; ADAM metallopeptidase with thrombospondin type 1 motif, 7,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002537$IPR002870:Peptidase M12B, propeptide, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450009363$IPR010294:ADAM-TS Spacer 1, 450009938$IPR010909:PLAC, 450011909$IPR013273:Peptidase M12B, ADAM-TS, 450016643$IPR018358:Disintegrin, conserved site]
similar to hCG1991431; similar to COMPase; ADAM metallopeptidase with thrombospondin type 1 motif, 7,SMART[760000182$SM00209:TSP1]
similar to hCG1991431; similar to COMPase; ADAM metallopeptidase with thrombospondin type 1 motif, 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000743$hydrolase, 790000783$integrin, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
similar to hCG1991431; similar to COMPase; ADAM metallopeptidase with thrombospondin type 1 motif, 7,UP_SEQ_FEATURE[850002948$chain:A disintegrin and metalloproteinase with thrombospondin motifs 7, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850103526$domain:Disintegrin, 850104962$domain:Peptidase M12B, 850105021$domain:PLAC, 850105555$domain:TSP type-1 1, 850105566$domain:TSP type-1 2, 850105575$domain:TSP type-1 3, 850105576$domain:TSP type-1 4, 850105577$domain:TSP type-1 5, 850105578$domain:TSP type-1 6, 850105579$domain:TSP type-1 7, 850105580$domain:TSP type-1 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850114683$region of interest:Spacer, 850117294$sequence conflict, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118574$splice variant]
solute carrier organic anion transporter family, member 2B1,INTERPRO[450003667$IPR004156:Organic anion transporter polypeptide OATP]
solute carrier organic anion transporter family, member 2B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier organic anion transporter family, member 2B1,UP_SEQ_FEATURE[850061471$chain:Solute carrier organic anion transporter family member 2B1, 850104500$domain:Kazal-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
tetratricopeptide repeat domain 7B,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 7B,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 7B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 7B,UP_SEQ_FEATURE[850064040$chain:Tetratricopeptide repeat protein 7B, 850102576$compositionally biased region:Poly-Leu, 850106258$modified residue, 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117121$repeat:TPR 11, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850118574$splice variant]
thioredoxin domain containing 12 (endoplasmic reticulum),INTERPRO[450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450011036$IPR012335:Thioredoxin fold, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase, 450016249$IPR017936:Thioredoxin-like, 450016250$IPR017937:Thioredoxin, conserved site]
thioredoxin domain containing 12 (endoplasmic reticulum),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
thioredoxin domain containing 12 (endoplasmic reticulum),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001302$Redox-active center, 790001405$signal, 790001550$transit peptide]
thioredoxin domain containing 12 (endoplasmic reticulum),UP_SEQ_FEATURE[850000341$binding site:FAD, 850000344$binding site:FAD; via amide nitrogen and carbonyl oxygen, 850000345$binding site:FAD; via carbonyl oxygen, 850005862$chain:Apoptosis-inducing factor 1, mitochondrial, 850064220$chain:Thioredoxin domain-containing protein 12, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106285$nucleotide phosphate-binding region:FAD, 850111661$region of interest:FAD-dependent oxidoreductase, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
transmembrane protein 84,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
transmembrane protein 84,UP_SEQ_FEATURE[850066225$chain:Transmembrane protein 84, 850117295$sequence variant, 850118623$transmembrane region]
ubiquitin associated protein 1,INTERPRO[450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote]
ubiquitin associated protein 1,SMART[760000144$SM00165:UBA]
ubiquitin associated protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ubiquitin associated protein 1,UP_SEQ_FEATURE[850068056$chain:Ubiquitin-associated protein 1, 850105598$domain:UBA 1, 850105599$domain:UBA 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
vascular cell adhesion molecule 1,BBID[10000045$17.Activators-CAM, 10000046$18.Cytokine_astocytes, 10000078$58.(CD40L)_immnosurveillance, 10000117$96.Immune_injury_MS-lesions_genetic_environ]
vascular cell adhesion molecule 1,BIOCARTA[30000169$h_LairPathway:Cells and Molecules involved in local acute inflammatory response, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes]
vascular cell adhesion molecule 1,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450003512$IPR003989:Vascular cell adhesion molecule-1, 450006486$IPR007110:Immunoglobulin-like, 450007701$IPR008424:Immunoglobulin C2-set, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
vascular cell adhesion molecule 1,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038873$hsa04670:Leukocyte transendothelial migration]
vascular cell adhesion molecule 1,PIR_SUPERFAMILY[630030191$PIRSF038689:vascular cell adhesion protein 1]
vascular cell adhesion molecule 1,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
vascular cell adhesion molecule 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
vascular cell adhesion molecule 1,UP_SEQ_FEATURE[850100065$chain:Vascular cell adhesion protein 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vestigial like 4 (Drosophila),INTERPRO[450006046$IPR006627:Protein of unknown function TDU]
vestigial like 4 (Drosophila),SMART[760000618$SM00711:TDU]
vestigial like 4 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
vestigial like 4 (Drosophila),UP_SEQ_FEATURE[850064941$chain:Transcription cofactor vestigial-like protein 4, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
zinc finger and BTB domain containing 37,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 37,PIR_SUPERFAMILY[630029438$PIRSF037869:Zinc finger and BTB domain-containing protein]
zinc finger and BTB domain containing 37,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 37,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 37,UP_SEQ_FEATURE[850101240$chain:Zinc finger and BTB domain-containing protein 37, 850103177$domain:BTB, 850117294$sequence conflict, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
zinc finger protein 107,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 107,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 107,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 107,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 107,UP_SEQ_FEATURE[850101434$chain:Zinc finger protein 107, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118664$zinc finger region:C2H2-type 12; atypical, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118677$zinc finger region:C2H2-type 17; atypical, 850118680$zinc finger region:C2H2-type 18; atypical, 850118683$zinc finger region:C2H2-type 19; atypical, 850118685$zinc finger region:C2H2-type 1; atypical, 850118688$zinc finger region:C2H2-type 2, 850118689$zinc finger region:C2H2-type 20, 850118691$zinc finger region:C2H2-type 21, 850118693$zinc finger region:C2H2-type 22, 850118695$zinc finger region:C2H2-type 23, 850118697$zinc finger region:C2H2-type 24, 850118700$zinc finger region:C2H2-type 25; atypical, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118729$zinc finger region:C2H2-type 6; atypical, 850118731$zinc finger region:C2H2-type 7, 850118735$zinc finger region:C2H2-type 8; atypical, 850118738$zinc finger region:C2H2-type 9; atypical]
zinc finger, FYVE domain containing 27,INTERPRO[450000262$IPR000306:Zinc finger, FYVE-type, 450015781$IPR017455:Zinc finger, FYVE-related]
zinc finger, FYVE domain containing 27,OMIM_DISEASE[520004546$Spastic paraplegia 33]
zinc finger, FYVE domain containing 27,SMART[760000055$SM00064:FYVE]
zinc finger, FYVE domain containing 27,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790000937$metal-binding, 790001015$neurodegeneration, 790001212$polymorphism, 790001555$transmembrane, 790001648$zinc, 790001651$zinc-finger]
zinc finger, FYVE domain containing 27,UP_SEQ_FEATURE[850101397$chain:Zinc finger FYVE domain-containing protein 27, 850102580$compositionally biased region:Poly-Pro, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn, 850118819$zinc finger region:FYVE-type]
zyg-11 homolog A (C. elegans),INTERPRO[450010814$IPR011989:Armadillo-like helical]
zyg-11 homolog A (C. elegans),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
zyg-11 homolog A (C. elegans),UP_SEQ_FEATURE[850048583$chain:Protein zyg-11 homolog A, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850118574$splice variant]
